A detailed history of Prosperity Consulting Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Prosperity Consulting Group, LLC holds 11,794 shares of NVO stock, worth $1.05 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
11,794
Previous 3,354 251.64%
Holding current value
$1.05 Million
Previous $478,000 193.72%
% of portfolio
0.11%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$119.07 - $145.42 $1 Million - $1.23 Million
8,440 Added 251.64%
11,794 $1.4 Million
Q2 2024

Aug 08, 2024

SELL
$122.71 - $146.91 $4,662 - $5,582
-38 Reduced 1.12%
3,354 $478,000
Q1 2024

May 01, 2024

BUY
$102.11 - $135.92 $346,357 - $461,040
3,392 New
3,392 $435,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $200B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Prosperity Consulting Group, LLC Portfolio

Follow Prosperity Consulting Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosperity Consulting Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prosperity Consulting Group, LLC with notifications on news.